Abstract: New analysis identifies acute and post-acute care settings, similar to emergency rooms, hospitals, and professional nursing amenities, as the main places the place dangerous, cognition-altering medicines are first prescribed to older adults.
The learn about finds that sufferers with dementia are disproportionately more likely to be began on antipsychotics or benzodiazepines in those high-stress environments fairly than at their common physician’s workplace. Crucially, those prescriptions are “sticky,” with over part of dementia sufferers nonetheless taking the medicines a yr after the preliminary hospital-based prescription.
Key Information
- Disproportionate Initiation: Whilst simplest 22% of clinical visits for dementia sufferers occur in acute/post-acute settings, 43% in their antipsychotic prescriptions originate there.
- The “Sticky” Impact: Prescriptions initiated in those settings have a tendency to persist. Roughly 51% of dementia sufferers began on those medicines in a health center surroundings had been nonetheless taking them twelve months later.
- Inclined Populations: Sufferers with dementia or Cognitive Impairment No longer Dementia (CIND) are the perhaps to obtain those prescriptions, regardless of being on the very best chance for unwanted effects like falls, critical confusion (delirium), and re-hospitalization.
- Loss of Indication: This learn about follows prior UCLA analysis appearing that as much as 70% of prescriptions for Central Anxious Device (CNS)-active medicines lacked a documented medical explanation why for being prescribed.
- Centered Intervention: Researchers argue that to curb overprescribing, policymakers will have to center of attention at the “transition of care” moments when a affected person leaves a health center or nursing facility.
Supply: UCLA
Preliminary prescriptions for medicines affecting cognition, similar to antipsychotics, are disproportionately likelier to come back from acute and post-acute settings similar to emergency rooms, hospitals and professional nursing amenities than they’re from docs’ workplaces, new UCLA analysis suggests.
The biggest percentage of those medicines are prescribed for other people with cognitive impairment, similar to dementia, who’re in particular vulnerable to in poor health results related to those medicines similar to falls, confusion, and hospitalization.
“Drugs similar to antipsychotics and benzodiazepines are recognized to impact cognition, building up delirium, and building up fall chance for older adults,” stated Dr. Dan Ly, assistant professor of medication, department of common inner medication and well being products and services analysis on the David Geffen Faculty of Medication at UCLA and the VA Better Los Angeles and the lead creator at the analysis letter.
“As well as, prescriptions for those medicines are “sticky” and chronic; for instance, for older adults with dementia who’re prescribed this kind of medicines affecting cognition, over part proceed to take this kind of drugs a yr later.”
The findings shall be revealed April 28 within the peer-reviewed magazine JAMA Community Open.
There was a push to cut back prescriptions of those cognition-altering medicines, Ly stated.
“Our effects counsel that efforts to cut back those prescriptions may have the best affect if we center of attention on acute and post-acute settings,” he stated.
The researchers analyzed information from the Well being and Retirement Learn about (HRS) of adults elderly 66 years and older related to Medicare fee-for-service claims between Jan. 1, 2008 to Dec. 31, 2021.
They checked out 4 drugs categories: benzodiazepines, nonbenzodiazepine hypnotics, antipsychotics and anticholinergics. They tested the medical surroundings the place the prescription used to be first initiated, evaluating initiations from acute and post-acute settings (that still integrated professional nursing amenities) with initiations from docs’ workplaces.
Sufferers had been grouped into one among 3 classes: No cognitive impairment; cognitive impairment, however now not dementia (CIND); or dementia.
General, 14% of sufferers and not using a cognitive impairment, 17% of the ones with CIND, and 22% of other people with dementia won a brand new prescription for some of the cognition affecting medicines in acute and post-acute settings. Moreover, 38% of the ones and not using a cognitive impairment, 44% of the ones with CIND, and 51% of the ones with dementia persevered the use of the ones medicines a yr later.
When put next with total affected person visits to such settings, a disproportionate selection of those prescriptions had been initiated in acute and post-acute settings. As an example, 43% of antipsychotic medicines had been initiated in acute and post-acute settings for sufferers with dementia whilst simplest 22% of total affected person visits had been to such settings for sufferers with dementia.
“We had been stunned by means of simply how a lot more often medicines affecting cognition had been prescribed from non-office settings,” Ly stated. “We make clear the places of prescriptions for those medicines, taking into consideration higher focused on of interventions to cut back their prescribing.”
The findings are restricted by means of the researchers’ assumption that the closing surroundings the sufferers had been in used to be the place the prescriptions had been initiated. The next move within the analysis is to inspect the traits of suppliers who prescribe those medicines extra often, Ly stated.
“This paintings builds on our prior analysis, which discovered that as much as 70% of prescriptions for Central Anxious Device-active medicines lacked a documented medical indication. That highlighted an pressing want to curb dangerous overprescribing,” stated Dr. John N. Mafi, affiliate professor of medication on the Geffen Faculty and the learn about’s senior creator.
“Now, our newest learn about offers policymakers and clinicians a roadmap, pointing precisely to the place they will have to goal their interventions first: acute and post-acute care settings.”
Dr. Annie Yang, Mei Leng, Dr. Catherine Sarkisian, and Cheryl Damberg co-authored the paper.
Investment: This learn about used to be funded by means of award R01AG070017-01 (Dr Mafi), Beeson Rising Leaders in Getting old Analysis Occupation Building Award K76AG064392-01A1 (Dr Mafi), award RF1AG094784 (Dr Ly), Midcareer in Affected person-Orientated Getting old Analysis award 1K24AG04789 (Dr Sarkisian), and US Deprescribing Analysis Community award 1R33AG086944-01 (Dr Sarkisian) from the Nationwide Institute on Getting old, Nationwide Institutes of Well being; Analysis Occupation Building Award IK2HX003836 from the United States Division of Veterans Affairs Well being Device Analysis (Dr Ly), and UCLA Medical Translational Science Institute award UL1TR001881 (Dr Sarkisian) from the Nationwide Heart for Advancing Translational Sciences, Nationwide Institutes of Well being.
Key Questions Replied:
A: Hospitals and ERs are steadily coping with acute behavioral crises or critical agitation in dementia sufferers. Clinicians might use antipsychotics or sedatives to make sure rapid protection or organize “sundowning.” The issue is that those “transient” fixes steadily transform everlasting portions of the affected person’s day-to-day drugs record.
A: Past “mind fog,” those medicines considerably building up the chance of bodily harm. Antipsychotics and benzodiazepines intervene with steadiness and response time, resulting in a miles upper charge of hip fractures and head accidents from falls.
A: The analysis highlights a “roadmap” for higher care. Households will have to ask for a complete drugs reconciliation throughout health center discharge. Ask particularly: “Which of those meds are new, why had been they began, and when is the plan to forestall them?”
Editorial Notes:
- This text used to be edited by means of a Neuroscience Information editor.
- Magazine paper reviewed in complete.
- Further context added by means of our group of workers.
About this neurology and neuropharmacology analysis information
Writer: Enrique Rivero
Supply: UCLA
Touch: Enrique Rivero – UCLA
Symbol: The picture is credited to Neuroscience Information
Unique Analysis: Open get right of entry to.
“Initiation Setting and Persistence of Medications Affecting Cognition in Older Adults” by means of Dan P. Ly, Annie W. Yang, Mei Leng, Catherine Sarkisian, Cheryl L. Damberg, and John N. Mafi. JAMA Community Open
DOI:10.1001/jamanetworkopen.2026.10234
Summary
Initiation Environment and Endurance of Drugs Affecting Cognition in Older Adults
Drugs that adversely impact cognition, eg, antipsychotics, might building up delirium and fall chance amongst older adults, however they continue to be often prescribed.
To higher perceive the context in their prescribing, this learn about tested the medical settings wherein those medicines had been initiated and the velocity at which sufferers proceed to take them 1 yr later.
